A drug that makes most cancers more vulnerable to the body's immune system may mark a new era in treatment. That’s according to a study published in the journal Nature.
The medicine strips cancer cells of the "camouflage" they use to evade attack by the immune system.
In the study, some patients totally recovered from terminal bladder cancer.